Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
Edaravone, the first known free radical scavenger, has demonstrated cellular protective properties in animals and humans. Owing to its antioxidant activity, edaravone modulates oxidative damage in various diseases, especially neurodegenerative diseases. In 2015, edaravone was approved in Japan to tr...
Saved in:
Main Authors: | Sun Joo Cha (Author), Kiyoung Kim (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
by: HaEun Cho, et al.
Published: (2020) -
Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone
by: Hee Jo Han, et al.
Published: (2022) -
Glutathione S-Transferase Rescues Motor Neuronal Toxicity in Fly Model of Amyotrophic Lateral Sclerosis
by: Sun Joo Cha, et al.
Published: (2020) -
Glutathione in the Nervous System as a Potential Therapeutic Target to Control the Development and Progression of Amyotrophic Lateral Sclerosis
by: Kiyoung Kim
Published: (2021) -
Amyotrophic Lateral Sclerosis
Published: (2012)